This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Beijing Immunochina Pharmaceuticals Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Fuyin Xiong: Innovator in Chimeric Antigen Receptor Technology
Introduction
Fuyin Xiong is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs). His innovative work has the potential to advance cancer treatment and immunotherapy.
Latest Patents
Fuyin Xiong holds a patent titled "Optimization of Chimeric Antigen Receptor." This patent reflects his dedication to enhancing the efficacy of CAR technology, which is crucial for improving patient outcomes in cancer therapies. He has 1 patent to his name, showcasing his commitment to innovation in this vital area of research.
Career Highlights
Fuyin Xiong is currently employed at Beijing Immunochina Pharmaceuticals Co., Ltd. His role at the company allows him to work on cutting-edge research and development projects that aim to revolutionize cancer treatment. His expertise in CAR technology positions him as a key player in the biotechnology sector.
Collaborations
Fuyin collaborates with talented colleagues, including Feifei Qi and Ting He. Together, they contribute to the advancement of immunotherapy and the development of novel therapeutic strategies.
Conclusion
Fuyin Xiong is a dedicated inventor whose work in optimizing chimeric antigen receptors is paving the way for future advancements in cancer treatment. His contributions to biotechnology are invaluable, and his ongoing research promises to make a significant impact in the field.